• News

    Interview with Charlotte Teunissen on VJN

    Using Olink technology for multiplex protein biomarker discovery, Prof. Teunissen’s team are analyzing data from patients treated with natalizumab ...

    • News

    CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services

    Press release: UPPSALA, Sweden, Aug. 31, 2021 (GLOBE NEWSWIRE) -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to ...

    UK Biobank project extended to Explore 3072

    The UK Biobank Pharma Proteomics Project (UKB-PPP Consortium) has decided to expand the ongoing proteomics study of 53,000 ...

    Announcing Olink Explore 3072

    Customers can now pre-order the next evolution of our Olink® Explore platform for high-throughput protein biomarker discovery, which ...

    High throughput proteomics as part of a multiomics approach to COVID 19 research

    New clinical trial arm for the SCALLOP consortium

    Maximizing the power of proteomic clinical trial profiling for better, actionable insights – a new collaborative initiative from the SCALLOP consortium.

    Available soon – Olink Signature

    Olink Signature Q100 provides a new, dedicated solution for Olink panels Target 96/48 panels that will enable researchers to ...

    What protein biomarkers reveal about the tumor microenvironment

    The following webinar details how protein biomarker research is being used to better understand ICB treatment response in cancer patients, ...

    Olink data at the Select Science Immunotherapy Virtual Summit

    SelectScience invites scientists from across the globe to explore the important developments in cancer and immunology research to advance research ...

    Next generation plasma profiling to monitor health and disease – the first Olink Explore publication!

    A major study from KTH in Stockholm is the first paper to be published describing a longitudinal wellness study as ...